Literature DB >> 23647131

Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.

Joaquín Jordán1, José M Ruíz-Moreno.   

Abstract

INTRODUCTION: The blood-retinal barrier (BRB) is required for proper vision and controls exchange of nutrients with the choroidal vessels. This barrier serves as a selective partition between the retina and the circulation, and to maintain the specialized environment of the neural retina with a high degree of control of solute and fluid permeability. AREAS COVERED: The authors review the understanding of retinal drug disposition. The article highlights the routes of ocular drug delivery, and discusses the newest pharmaceutical ophthalmic formulations. Furthermore, the article focuses on drug transporters that are expressed in the corneal epithelium and BRB (ATP-binding cassette and solute carrier superfamilies). These transporters play essential roles in mediating the biodisponibility of drugs in the anterior and posterior chambers of the eye. Finally, the article reviews the ocular complications that are caused by intravitreal injections. EXPERT OPINION: Intraocular drug delivery is the only mode that currently directly broaches the BRB and thereby attains the highest peak intravitreal or intraretinal drug concentration. There is an urgent need for the development of optimal and efficient drug delivery systems.

Mesh:

Substances:

Year:  2013        PMID: 23647131     DOI: 10.1517/17425255.2013.796928

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  6 in total

1.  Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.

Authors:  Ana Paula Resende; Beatriz Silva; Berta São Braz; Telmo Nunes; Lídia Gonçalves; Esmeralda Delgado
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

2.  Differential expression of breast cancer-resistance protein, lung resistance protein, and multidrug resistance protein 1 in retinas of streptozotocin-induced diabetic mice.

Authors:  Meng-Shuang Li; Meng Xin; Chuan-Long Guo; Gui-Ming Lin; Jun Li; Xiang-Gen Wu
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

3.  Effects of Oral Vitamin D Supplement Therapy on Clinical Outcomes of Intravitreal Bevacizumab in Diabetic Macular Edema.

Authors:  Saeed Karimi; Vahid Movafaghi; Amir Arabi; Toktam Shahraki; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20

4.  Activity of crizotinib over choroidal metastases in non-small-cell lung cancer (NSCLC)-ALK rearranged: a case report.

Authors:  Alessandra Bearz; Sandra Santarossa; Antonio Manfrè; Giorgio Beltrame; Martina Urbani; Ivana Sartor; Valentina Da Ros; Umberto Tirelli
Journal:  BMC Res Notes       Date:  2014-09-02

5.  Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review.

Authors:  Fabien Bévalot; Nathalie Cartiser; Charline Bottinelli; Laurent Fanton; Jérôme Guitton
Journal:  Forensic Toxicol       Date:  2015-10-28       Impact factor: 4.096

6.  ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure.

Authors:  Myriam El Biali; Rudolf Karch; Cécile Philippe; Helmuth Haslacher; Nicolas Tournier; Marcus Hacker; Markus Zeitlinger; Doreen Schmidl; Oliver Langer; Martin Bauer
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.